Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVE: Minimal Ventilation and Dexamethasone in Extremely-Low-Birth-Weight Infants
NCT00005777Phase 3Terminated
- Sponsor
- NICHD Neonatal Research Network
- Start
- Feb 1998
- Primary completion
- Sep 1998
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in bronchopulmonary dysplasia (BPD) (4 arms), sponsored by NICHD Neonatal Research Network. Primary endpoint: Death or moderate to severe bronchopulmonary dysplasia. Started Feb 1998; status: terminated.
02
Drugs
dexamethasone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT00005777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005777.